Monoclonal Gammopathy of Undetermined Significance (MGUS): Indications for Pre-Diagnostic Testing, Subsequent Diagnoses, and Follow-up Practice
Conclusions: Approximately 1/3 of MGUS diagnoses were made during the evaluation of signs and symptoms not related to lymphoplasmacytic malignancies. The subsequent diagnoses found were a wide variety of common diseases. Most MGUS diagnoses were made by general internists, neurologists, and nephrologists. Follow-up practices varied between hematologists and non-hematologists. Nearly 1/3 of the oldest old patients continued to have follow-up, despite limited life expectancy.DisclosuresNo relevant conflicts of interest to declare.
Source: Blood - Category: Hematology Authors: Ravindran, A., Lackore, K. A., Glasgow, A. E., Drake, M. T., Go, R. S. Tags: 901. Health Services Research-Non-Malignant Conditions: Poster I Source Type: research
More News: Amyloidosis | Anemia | Brain | Cancer & Oncology | Cardiology | Chronic Kidney Disease | Congestive Heart Failure | Dermatitis | Dermatology | Heart | Heart Failure | Hematology | Internal Medicine | Laboratory Medicine | Macroglobulinemia | Myeloma | Neurology | Orthopaedics | Osteoporosis | Study | Urology & Nephrology | Waldenstrom's Macroglobulinemia